R.Gangakhedkar city New Delhi India virus covid-19 patient R.Gangakhedkar city New Delhi India

Monoclonal antibody cocktail unlikely to cause further mutations of Covid-19 virus: Ex-ICMR Chief

Reading now: 985
www.livemint.com

New Delhi: Monoclonal antibody cocktail, used for the treatment of COVID-19, is unlikely to lead to further mutation of the virus, said Dr Raman R Gangakhedkar, former Head Scientist of Epidemiology and Communicable Diseases at the Indian Council of Medical Research (ICMR) on Sunday.Speaking to ANI, Gangakhedkar also said that when a person develops moderate to severe illness, it's more likely due to a dysregulated immune response rather than the virus itself."I don't think that it will lead to mutation theory-wise because we know when the person develops moderate to severe illness we also know that it's more likely due to dysregulated immunity response rather than the virus itself.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA